MAPT and Mental deterioration: Tau pathophysiology can also be evaluated by measuring phosphorylated tau concentrations in the CSF, and several studies have provided additional evidence that tau PET is more strongly coupled to cognitive decline, whereas CSF p-tau181 is more tightly linked to preclinical AD [9–12].